Risk preference mood spreads, temporarily recovering to the 0.04 million yen level for the first time in 3 months.
The Nikkei average rose for the fourth consecutive business day. It closed at 39,910.55 yen, up 304.75 yen (with an estimated volume of 1.8 billion 50 million shares traded). Following the rise of major stock price indices in the US market the previous day, the Nikkei average began trading near the 0.04 million yen mark for the first time in about three months since July 19th. Subsequently, amidst a sense of immediate achievement due to reaching this milestone, there was a mix of buying and selling, with a battle continuing around the 0.04 million yen mark. While the day ended with the closing at today's lowest price, it
The Nikkei Average rose for the fourth day, temporarily recovering to the 40,000 yen level, but concerns arise due to the decline in Asian stocks etc.
On the 14th, the US stock market continued to rise. The Dow Jones Industrial Average closed at 43,065.22, up 201.36 points, and the Nasdaq closed at 18,502.69, up 159.75 points. Following speculation of a slight interest rate cut leading to selling pressure and buying driven by expectations of demand recovery against the backdrop of additional fiscal policies by the Chinese government, the market opened with mixed results. Subsequently, expectations for earnings of major companies provided support, pushing the market higher. Furthermore, the rise of semiconductor Nvidia pushed up the Nasdaq, leading to gains towards the end of the trading session.
Stocks that hit the daily limit up or down in the morning session.
■Stock prices limit up <260A> Olts <3046> Jinz Holdings <3350> Metaplanet <3760> Cave <3985> Temona <6467> Nichidai <7868> Hiroshi Hall Holdings ■Stock prices limit down <2553> One etf South China A shares CSI500 <2628> iFree China Star 50 <7603> Mac House ※Includes temporary limit up and down (indicative price)
Rakuten G, Asahi Kasei, etc. (additional) Rating
Downgrade - Bearish Code Stock Name Securities Company Former Changed After -------------------------------------------------- <3349> Cosmos Pharmaceuticals McCollie 'Out P' 'Neutral' Target Stock Price Changed Code Stock Name Securities Company Former Changed After -------------------------------------------------- <3349> Cosmos Pharmaceuticals
Marumae ranks in, operating profit decreased by 81% in the previous period, but is expected to increase by 10.2 times in the current period.
Marumae <6264> is ranked (as of 9:32 a.m.). It has surged. They announced their financial results for the fiscal year ending in August 24th after the close of trading last weekend. Operating profit is 15.6 million yen (down 81.8% from the previous period). The previous financial estimates were 15.5 million yen. The operating profit for the fiscal year ending in August 25th is expected to be 1.6 billion yen (10.2 times higher than the previous period). In the semiconductor sector, they expect investment in logic foundries and DRAM equipment to continue due to the vibrant demand for AI, while also resuming investment in NAND. Volume changes.
October 15th [Today's Investment Strategy]
[Fisco Selected Stock] [Material Stock] Cosmos Pharmaceuticals <3349> 7320 yen (10/11) A drugstore based in Kyushu. They announced their first quarter results. Operating profit increased by 28.8% year-on-year to 11.5 billion yen. Despite a temporary decline in profitability due to in-house competition, they carried out new store openings and expanded their store network to new business territories without hesitation. The operating profit for the fiscal year ending in May 2025 is expected to be 31.6 billion yen, a 0.3% increase from the previous period. The progress rate for the first quarter compared to the full-year forecast is 36.6%. The full-year forecast is for a slight increase in profit.